Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.54−0.24 (-8.63%)
Close on Nov 18, 2026Market cap $21.18MP/E –Yield –
Evaxion A/S shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 320M, up 497.3% from the year before. The highest annual figure on record is 320M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 320M | +497.3% |
| FY2024 | Dec 31, 2024 | 54M | +96.2% |
| FY2023 | Dec 31, 2023 | 27M | +15.6% |
| FY2022 | Dec 31, 2022 | 24M | +21.3% |
| FY2021 | Dec 31, 2021 | 19M | +26.3% |
| FY2020 | Dec 31, 2020 | 15M | +11.1% |
| FY2019 | Dec 31, 2019 | 14M | +7.6% |
| FY2018 | Dec 31, 2018 | 13M | – |
See a number that looks wrong?